Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
results tags : Covid save search
Tonix Pharmaceuticals Announces Topline Results from Phase 2 PREVAIL Proof-of-Concept Study of TNX-102 SL for the Management of Fibromyalgia-Type Long COVID
Published: 2023-09-05 (Crawled : 11:00) - globenewswire.com
TNXP | $0.1594 2.57% 1.3M
|
Health Technology
|
| O: -9.08%
H: 0.0%
C: 0.0%
tnx-102 management covid pharmaceuticals topline results study
Positive Phase 2 Topline Results Show Novavax's COVID-Influenza Combination, Stand-alone Influenza and High-dose COVID Vaccine Candidates Demonstrate Robust Immune Responses
Published: 2023-05-09 (Crawled : 12:00) - biospace.com/
SNY | News | $47.85 1.49% 920K
|
Health Technology
|
| O: -0.58%
H: 0.0%
C: 0.0%
NVAX | $4.22 3.69% 2M
|
Health Technology
|
| O: 20.4%
H: 26.64%
C: 6.13%
covid vaccine positive influenza topline results show
eFFECTOR Therapeutics Announces Positive Top-Line Results from Phase 1b Clinical Trial of Zotatifin for the Treatment of COVID
Published: 2023-02-21 (Crawled : 15:00) - globenewswire.com
EFTR | $1.92 7.87% 83K
|
|
| O: -42.99%
H: 54.67%
C: 43.67%
treatment covid trial therapeutics positive
Akston Biosciences Announces Positive Interim Phase II Results from COVID “Universal” Booster Vaccine Trial
Published: 2022-11-01 (Crawled : 17:00) - biospace.com/
JNJ | News | $150.09 0.65% 4.9M
|
Health Technology
|
| O: -0.36%
H: 0.0%
C: 0.0%
covid vaccine trial positive results
Omeros Corporation Reports Narsoplimab Treatment Results in Critically Ill COVID-19 Patients in I-SPY COVID Trial
Published: 2022-09-15 (Crawled : 14:20) - biospace.com/
OMER | $3.17 2.92% 110K
|
Health Technology
|
| O: -5.57%
H: 2.16%
C: -21.61%
covid-19 treatment covid trial corporation results
Axcella Announces Highly Promising Results from Phase 2a Placebo Controlled Clinical Trial for Long COVID
Published: 2022-08-02 (Crawled : 11:00) - biospace.com/
AXLA | $4.58 -56.33% 42K
|
Health Technology
|
| O: 4.12%
H: 6.93%
C: 0.5%
covid trial phase 2b
Tonix Pharmaceuticals Announces Results of Retrospective Observational Database Study In Over 50,000 Long COVID Patients
Published: 2022-04-20 (Crawled : 12:20) - biospace.com/
TNXP | $0.1594 2.57% 1.3M
|
Health Technology
|
| O: 4.26%
H: 1.49%
C: -2.7%
covid results
Sorrento Reports Promising Results With a Universal Chimeric mRNA COVID-19 Vaccine That Elicits Potent Neutralizing Antibodies and Protection Against Omicron (BA.1 and BA.2) and Delta Variants
Published: 2022-03-20 (Crawled : 00:00) - globenewswire.com
SRNE | $0.015 140K
|
Health Technology
|
| O: 3.44%
H: 1.48%
C: -7.38%
covid-19 covid report results vaccine antibody
Eiger BioPharmaceuticals to Host Conference Call to Discuss Phase 3 TOGETHER Study Results of Peginterferon Lambda for COVID-19 on Thursday, March 17, 2022
Published: 2022-03-16 (Crawled : 22:00) - biospace.com/
EIGR | $1.725 -1.45% 140K
|
Health Technology
|
| O: 1.28%
H: 3.62%
C: 3.08%
covid-19 day als biopharma conference covid results phase 3
Innovation Pharmaceuticals Reports Additional Findings Based on Review of Brilacidin Phase 2 COVID-19 Trial Results and Compassionate Use Cases
Published: 2022-03-07 (Crawled : 13:30) - biospace.com/
IPIX | $0.0042 1.4K
|
Manufacturing
|
| O: -2.26%
H: 8.72%
C: -5.13%
covid-19 phase 2 als trial trial results covid report results
RedHill Announces Positive Phase 2 Study Results with Oral RHB-107 in Non-Hospitalized COVID-19
Published: 2022-03-01 (Crawled : 14:30) - biospace.com/
RDHL | $0.4249 -3.96% 310K
|
Health Technology
|
| O: 0.46%
H: 0.45%
C: -10.45%
rhb-107 covid-19 phase 2 covid positive
Bavarian Nordic Reports Additional Positive Phase 2 Results for its COVID-19 Vaccine Candidate Ahead of Phase 3 Trial
Published: 2022-02-28 (Crawled : 07:00) - globenewswire.com
JNJ | News | $150.09 0.65% 4.9M
|
Health Technology
|
| O: 1.79%
H: 0.0%
C: 0.0%
covid-19 phase 2 trial covid report positive phase 2 results results vaccine phase 3
Novavax Announces Positive Results of COVID-19 Vaccine in Pediatric Population of PREVENT-19 Phase 3 Clinical Trial
Published: 2022-02-10 (Crawled : 00:00) - biospace.com/
NVAX | $4.22 3.69% 2M
|
Health Technology
|
| O: -4.98%
H: 0.0%
C: 0.0%
covid-19 trial covid event-19 positive results positive vaccine phase 3
Galecto Publishes Results Showing Safety and Efficacy of the GB0139 Inhaled Galectin-3 Inhibitor in Hospitalized COVID-19 Patients on Standard of Care
Published: 2022-01-27 (Crawled : 13:00) - biospace.com/
GLTO | $0.681 45K
|
Health Technology
|
| O: 1.79%
H: 3.07%
C: -0.44%
gb0139 covid-19 galectin-3 covid results
Todos Medical to Announce Topline Results from Tollovir™ Phase 2 Clinical Trial from the Treatment of Hospitalized COVID-19 Patients on January 27th, 2022
Published: 2022-01-12 (Crawled : 15:00) - globenewswire.com
TOMDF | $0.0001 100.0% 14M
|
Manufacturing
|
| O: 5.45%
H: 20.83%
C: 1.67%
covid-19 treatment phase 2 trial covid tollovir topline results results topline
Gritstone Announces Positive Clinical Results from First Cohort of a Phase 1 Study (CORAL-BOOST) Evaluating a T Cell-Enhanced Self-Amplifying mRNA (samRNA) Vaccine Against COVID-19
Published: 2022-01-04 (Crawled : 15:30) - biospace.com/
GRTS | $0.748 0.34% 2M
|
Health Technology
|
| O: -1.56%
H: 0.83%
C: -41.5%
covid-19 covid cel phase 1 positive results vaccine t-cell
Kiniksa Announces Results from Phase 3 Trial of Mavrilimumab in COVID-19-Related ARDS
Published: 2021-12-28 (Crawled : 13:30) - biospace.com/
KNSA | $17.92 4.83% 340K
|
Health Technology
|
| O: -11.69%
H: 13.24%
C: 9.97%
covid-19 trial covid results phase 3
Pluristem Reports Topline Results from its Phase II Studies of Acute Respiratory Distress Syndrome Associated with COVID-19
Published: 2021-12-27 (Crawled : 12:30) - globenewswire.com
PSTI | $1.0 -2.91% 8.0%
|
Health Technology
|
| O: -7.73%
H: 0.0%
C: -10.06%
covid-19 respiratory covid topline results results topline syndros
OPKO Health Announces Topline Results from Phase 2 Trial Evaluating RAYALDEE to Treat Symptomatic COVID-19 Outpatients
Published: 2021-12-23 (Crawled : 14:00) - biospace.com/
OPK | $1.245 1.22% 1.2M
|
Health Technology
|
| O: 0.87%
H: 4.09%
C: 2.58%
covid-19 health phase 2 trial covid topline results results topline
UAB and Mereo Announce Positive Top-line Results from “COSTA” a Phase 1b/2 Trial of Alvelestat (MPH966) in Hospitalized Patients with COVID-19 Respiratory Disease
Published: 2021-12-22 (Crawled : 12:30) - globenewswire.com
MREO | $2.815 0.9% 400K
|
Health Technology
|
| O: 0.61%
H: 0.6%
C: -3.01%
mph966 covid-19 respiratory phase 1b trial covid disease phase 1 positive results topline phase 2b alvelestat
Gainers vs Losers
| 87% | 13% |
Top 10 Gainers
MTTR | News M | $4.64 166.67% 18M
|
AGBA | $2.74 119.2% 52M
|
Finance
CZOO | $9.07 81.76% 22M
|
EDBL | News | $6.56 74.47% 1.8M
|
OPRT | News | $3.37 49.78% 8.9M
|
Finance
MTC | $2.14 37.18% 4.9M
|
Technology Services
VNRX | $0.7945 32.42% 3.1M
|
Health Technology
MLEC | $1.79 27.86% 2.6M
|
n/a
BTCM | $3.45 27.78% 640K
|
Arts, Entertainment, and Recrea...
PALI | $6.29 27.59% 22M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.